X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
0.611
+0.004 (0.66%)
At close: Dec 20, 2024, 4:00 PM
0.640
+0.029 (4.69%)
After-hours: Dec 20, 2024, 4:50 PM EST
X4 Pharmaceuticals Market Cap
X4 Pharmaceuticals has a market cap or net worth of $104.26 million as of December 20, 2024. Its market cap has decreased by -30.87% in one year.
Market Cap
104.26M
Enterprise Value
47.48M
1-Year Change
-30.87%
Ranking
Category
Stock Price
$0.61
Market Cap Chart
Since March 14, 2019, X4 Pharmaceuticals's market cap has increased from $101.77M to $104.26M, an increase of 2.44%. That is a compound annual growth rate of 0.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 104.26M | -25.68% |
| Dec 29, 2023 | 140.27M | 16.23% |
| Dec 30, 2022 | 120.68M | 87.36% |
| Dec 31, 2021 | 64.41M | -38.49% |
| Dec 31, 2020 | 104.72M | -39.22% |
| Dec 31, 2019 | 172.30M | 69.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tonix Pharmaceuticals Holding | 106.53M |
| Leap Therapeutics | 106.52M |
| MediciNova | 105.94M |
| PetMed Express | 105.23M |
| Quipt Home Medical | 103.78M |
| Champions Oncology | 103.43M |
| MDxHealth | 102.14M |
| Regulus Therapeutics | 101.53M |